Gilead Sciences Market Cap

Gilead Sciences has a market cap or net worth of 95.03 billion as of May 14, 2025. Its market cap has increased by 45.32% in one year.

Market Cap

95.03B

Enterprise Value

107.20B

Revenue

22.24B

Ranking

n/a

PE Ratio

20.58

Stock Price

103.92

Market Cap Chart

Since January 22, 1992, Gilead Sciences's market cap has increased from 138.73M to 95.03B, an increase of 68,398.69%. That is a compound annual growth rate of 21.64%.

Market Cap History

Date	Market Cap	% Change
May 13, 2025	95.03B	3.34%
Dec 31, 2024	91.95B	16.03%
Dec 29, 2023	79.25B	-11.32%
Dec 30, 2022	89.37B	32.86%
Dec 31, 2021	67.26B	25.75%
Dec 31, 2020	53.49B	-13.83%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	157.85B
HSBC Holdings	153.32B
Shell	150.74B
Unilever	113.95B
Rio Tinto Group	80.56B
RELX PLC	72.63B
Rolls-Royce Holdings	67.02B
British American Tobacco p.l.c.	66.46B

Market Cap Rankings